vs
百济神州（ONC）与RXO, Inc.（RXO）财务数据对比。点击上方公司名可切换其他公司
百济神州的季度营收约是RXO, Inc.的1.0倍（$1.5B vs $1.5B），百济神州净利率更高（4.4% vs -3.1%，领先7.6%），百济神州同比增速更快（32.8% vs -11.9%），百济神州自由现金流更多（$379.8M vs $-9.0M），过去两年百济神州的营收复合增速更高（41.2% vs 26.8%）
BeOne Medicines（原百济神州）是一家跨国肿瘤领域制药企业，专注于癌症治疗创新药物的研发与商业化，致力于为全球癌症患者提供更有效、可及性更高的治疗方案，改善患者的生存质量与预后。
RXO是总部位于美国的头部运输及物流解决方案供应商，核心业务覆盖货运经纪、大件商品最后一公里配送、运输管理服务与全链路供应链优化支持，主要服务北美制造业、零售业及电商领域的客户。
ONC vs RXO — 直观对比
营收规模更大
ONC
是对方的1.0倍
$1.5B
营收增速更快
ONC
高出44.7%
-11.9%
净利率更高
ONC
高出7.6%
-3.1%
自由现金流更多
ONC
多$388.8M
$-9.0M
两年增速更快
ONC
近两年复合增速
26.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.5B |
| 净利润 | $66.5M | $-46.0M |
| 毛利率 | 90.5% | — |
| 营业利润率 | 12.4% | -2.9% |
| 净利率 | 4.4% | -3.1% |
| 营收同比 | 32.8% | -11.9% |
| 净利润同比 | 143.8% | -84.0% |
| 每股收益（稀释后） | $0.05 | $-0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ONCRXO
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.3B | $1.4B | ||
| Q1 25 | $1.1B | $1.4B | ||
| Q4 24 | $1.1B | $1.7B | ||
| Q3 24 | $1.0B | $1.0B | ||
| Q2 24 | $929.2M | $930.0M | ||
| Q1 24 | $751.7M | $913.0M |
净利润ONCRXO
| Q4 25 | $66.5M | $-46.0M | ||
| Q3 25 | $124.8M | $-14.0M | ||
| Q2 25 | $94.3M | $-9.0M | ||
| Q1 25 | $1.3M | $-31.0M | ||
| Q4 24 | $-151.9M | $-25.0M | ||
| Q3 24 | $-121.3M | $-243.0M | ||
| Q2 24 | $-120.4M | $-7.0M | ||
| Q1 24 | $-251.2M | $-15.0M |
毛利率ONCRXO
| Q4 25 | 90.5% | — | ||
| Q3 25 | 86.1% | — | ||
| Q2 25 | 87.5% | — | ||
| Q1 25 | 85.2% | — | ||
| Q4 24 | 85.8% | — | ||
| Q3 24 | 83.0% | — | ||
| Q2 24 | 85.1% | — | ||
| Q1 24 | 83.4% | — |
营业利润率ONCRXO
| Q4 25 | 12.4% | -2.9% | ||
| Q3 25 | 11.5% | -0.5% | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | 1.0% | -2.1% | ||
| Q4 24 | -7.0% | -1.4% | ||
| Q3 24 | -12.0% | -1.9% | ||
| Q2 24 | -11.5% | — | ||
| Q1 24 | -34.8% | -1.3% |
净利率ONCRXO
| Q4 25 | 4.4% | -3.1% | ||
| Q3 25 | 8.8% | -1.0% | ||
| Q2 25 | 7.2% | -0.6% | ||
| Q1 25 | 0.1% | -2.2% | ||
| Q4 24 | -13.5% | -1.5% | ||
| Q3 24 | -12.1% | -23.4% | ||
| Q2 24 | -13.0% | -0.8% | ||
| Q1 24 | -33.4% | -1.6% |
每股收益（稀释后）ONCRXO
| Q4 25 | $0.05 | $-0.28 | ||
| Q3 25 | $0.08 | $-0.08 | ||
| Q2 25 | $0.06 | $-0.05 | ||
| Q1 25 | $0.00 | $-0.18 | ||
| Q4 24 | $-0.10 | $-0.17 | ||
| Q3 24 | $-0.09 | $-1.81 | ||
| Q2 24 | $-0.09 | $-0.06 | ||
| Q1 24 | $-0.19 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $17.0M |
| 总债务越低越好 | $836.4M | $387.0M |
| 股东权益账面价值 | $4.4B | $1.5B |
| 总资产 | $8.2B | $3.3B |
| 负债/权益比越低杠杆越低 | 0.19× | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资ONCRXO
| Q4 25 | $4.5B | $17.0M | ||
| Q3 25 | $4.0B | $25.0M | ||
| Q2 25 | $2.8B | $18.0M | ||
| Q1 25 | $2.5B | $16.0M | ||
| Q4 24 | $2.6B | $35.0M | ||
| Q3 24 | $2.7B | $55.0M | ||
| Q2 24 | $2.6B | $7.0M | ||
| Q1 24 | $2.8B | $7.0M |
总债务ONCRXO
| Q4 25 | $836.4M | $387.0M | ||
| Q3 25 | — | $387.0M | ||
| Q2 25 | — | $387.0M | ||
| Q1 25 | — | $387.0M | ||
| Q4 24 | — | $351.0M | ||
| Q3 24 | — | $352.0M | ||
| Q2 24 | — | $370.0M | ||
| Q1 24 | — | $351.0M |
股东权益ONCRXO
| Q4 25 | $4.4B | $1.5B | ||
| Q3 25 | $4.1B | $1.6B | ||
| Q2 25 | $3.8B | $1.6B | ||
| Q1 25 | $3.5B | $1.6B | ||
| Q4 24 | $3.3B | $1.6B | ||
| Q3 24 | $3.4B | $1.7B | ||
| Q2 24 | $3.4B | $579.0M | ||
| Q1 24 | $3.4B | $582.0M |
总资产ONCRXO
| Q4 25 | $8.2B | $3.3B | ||
| Q3 25 | $7.6B | $3.2B | ||
| Q2 25 | $6.3B | $3.2B | ||
| Q1 25 | $5.8B | $3.3B | ||
| Q4 24 | $5.9B | $3.4B | ||
| Q3 24 | $5.8B | $3.4B | ||
| Q2 24 | $5.7B | $1.8B | ||
| Q1 24 | $5.7B | $1.8B |
负债/权益比ONCRXO
| Q4 25 | 0.19× | 0.25× | ||
| Q3 25 | — | 0.24× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.64× | ||
| Q1 24 | — | 0.60× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $417.3M | $7.0M |
| 自由现金流经营现金流 - 资本支出 | $379.8M | $-9.0M |
| 自由现金流率自由现金流/营收 | 25.4% | -0.6% |
| 资本支出强度资本支出/营收 | 2.5% | 1.1% |
| 现金转化率经营现金流/净利润 | 6.28× | — |
| 过去12个月自由现金流最近4个季度 | $941.7M | $-8.0M |
8季度趋势，按日历期对齐
经营现金流ONCRXO
| Q4 25 | $417.3M | $7.0M | ||
| Q3 25 | $402.6M | $23.0M | ||
| Q2 25 | $263.6M | $23.0M | ||
| Q1 25 | $44.1M | $-2.0M | ||
| Q4 24 | $75.2M | $-7.0M | ||
| Q3 24 | $188.4M | $-7.0M | ||
| Q2 24 | $-95.6M | $-5.0M | ||
| Q1 24 | $-308.6M | $7.0M |
自由现金流ONCRXO
| Q4 25 | $379.8M | $-9.0M | ||
| Q3 25 | $354.5M | $9.0M | ||
| Q2 25 | $219.8M | $9.0M | ||
| Q1 25 | $-12.3M | $-17.0M | ||
| Q4 24 | $-17.3M | $-19.0M | ||
| Q3 24 | $54.7M | $-18.0M | ||
| Q2 24 | $-205.5M | $-16.0M | ||
| Q1 24 | $-465.1M | $-4.0M |
自由现金流率ONCRXO
| Q4 25 | 25.4% | -0.6% | ||
| Q3 25 | 25.1% | 0.6% | ||
| Q2 25 | 16.7% | 0.6% | ||
| Q1 25 | -1.1% | -1.2% | ||
| Q4 24 | -1.5% | -1.1% | ||
| Q3 24 | 5.5% | -1.7% | ||
| Q2 24 | -22.1% | -1.7% | ||
| Q1 24 | -61.9% | -0.4% |
资本支出强度ONCRXO
| Q4 25 | 2.5% | 1.1% | ||
| Q3 25 | 3.4% | 1.0% | ||
| Q2 25 | 3.3% | 1.0% | ||
| Q1 25 | 5.0% | 1.0% | ||
| Q4 24 | 8.2% | 0.7% | ||
| Q3 24 | 13.3% | 1.1% | ||
| Q2 24 | 11.8% | 1.2% | ||
| Q1 24 | 20.8% | 1.2% |
现金转化率ONCRXO
| Q4 25 | 6.28× | — | ||
| Q3 25 | 3.22× | — | ||
| Q2 25 | 2.79× | — | ||
| Q1 25 | 34.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ONC
暂无分部数据
RXO
| Retail Sector | $546.0M | 37% |
| Last Mile | $298.0M | 20% |
| Food And Beverage Sector | $225.0M | 15% |
| Other Sector | $185.0M | 13% |
| Managed Transportation | $133.0M | 9% |
| Automotive Sector | $93.0M | 6% |
